Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
183
4.030
Why?
Proteins
17
2010
339
2.420
Why?
Neovascularization, Pathologic
17
2022
155
2.400
Why?
Calixarenes
7
2017
9
1.940
Why?
Melanoma, Experimental
6
2021
40
1.820
Why?
Galectin 1
8
2024
20
1.810
Why?
Antineoplastic Agents
14
2024
1172
1.560
Why?
Peptides
20
2017
221
1.360
Why?
Mice
47
2024
5687
1.280
Why?
Neoplasms
14
2024
1251
1.200
Why?
Animals
53
2024
13124
1.050
Why?
Endothelial Cells
10
2022
258
1.040
Why?
Lung Neoplasms
5
2024
601
1.040
Why?
Gold
7
2023
128
0.870
Why?
Ovarian Neoplasms
8
2008
450
0.870
Why?
Oxygen
6
2020
321
0.850
Why?
Cell Line, Tumor
18
2024
1398
0.800
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
154
0.770
Why?
Carcinoma, Squamous Cell
4
2019
326
0.740
Why?
Proto-Oncogene Proteins c-met
1
2021
18
0.730
Why?
Peptide Fragments
5
2013
209
0.710
Why?
Mammary Neoplasms, Experimental
6
2015
121
0.710
Why?
Radiation-Sensitizing Agents
4
2023
51
0.700
Why?
Head and Neck Neoplasms
3
2019
287
0.680
Why?
Carcinoma, Lewis Lung
1
2019
9
0.670
Why?
Molecular Targeted Therapy
2
2018
123
0.650
Why?
Protein Kinase Inhibitors
1
2021
204
0.640
Why?
Preservation, Biological
1
2018
8
0.630
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
76
0.630
Why?
Anti-Bacterial Agents
4
2019
745
0.620
Why?
Radiation Tolerance
5
2020
84
0.620
Why?
CD8-Positive T-Lymphocytes
1
2019
125
0.620
Why?
Galectins
1
2018
5
0.600
Why?
Metal Nanoparticles
4
2023
80
0.570
Why?
Hyperthermia, Induced
3
2019
115
0.550
Why?
Bacteria
1
2018
218
0.550
Why?
Mice, Nude
12
2019
248
0.540
Why?
Radiotherapy
5
2021
125
0.530
Why?
Xenograft Model Antitumor Assays
11
2020
212
0.510
Why?
Pseudomonas aeruginosa
2
2013
72
0.480
Why?
Combined Modality Therapy
11
2020
641
0.430
Why?
Benzofurans
2
2012
18
0.430
Why?
Cytotoxins
1
2013
15
0.420
Why?
Cell Proliferation
10
2024
985
0.410
Why?
Pseudomonas Infections
1
2013
48
0.410
Why?
Drug Design
4
2014
119
0.410
Why?
Oxidation-Reduction
3
2024
316
0.410
Why?
Endothelium, Vascular
8
2010
251
0.400
Why?
Humans
44
2024
50503
0.400
Why?
Carbohydrate Metabolism
1
2012
26
0.400
Why?
Neoplasms, Experimental
4
2020
110
0.390
Why?
Nanostructures
3
2023
45
0.390
Why?
Benzeneacetamides
2
2024
12
0.390
Why?
Glutaminase
2
2024
18
0.390
Why?
Bacteremia
1
2013
89
0.390
Why?
Sesquiterpenes
3
2010
88
0.370
Why?
Angiostatic Proteins
1
2011
1
0.370
Why?
Immunity, Cellular
1
2011
63
0.360
Why?
Molecular Mimicry
2
2007
38
0.350
Why?
Cell Survival
8
2024
589
0.350
Why?
Dendritic Cells
3
2021
135
0.350
Why?
Endothelium
4
2022
37
0.340
Why?
Carboplatin
3
2024
54
0.330
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1000
0.330
Why?
Tumor Necrosis Factor-alpha
4
2019
393
0.320
Why?
Immunotherapy, Adoptive
1
2011
163
0.320
Why?
Cells, Cultured
8
2013
1571
0.310
Why?
Vascular Endothelial Growth Factor A
7
2022
182
0.310
Why?
Apoptosis
7
2024
1097
0.310
Why?
Intercellular Adhesion Molecule-1
5
2022
62
0.310
Why?
T-Lymphocytes
1
2011
325
0.310
Why?
Structure-Activity Relationship
6
2012
395
0.300
Why?
Polyethylene Glycols
3
2021
86
0.300
Why?
Mice, Inbred C57BL
8
2021
1808
0.300
Why?
Phototherapy
2
2019
42
0.290
Why?
Amino Acid Sequence
5
2012
574
0.290
Why?
Tumor Cells, Cultured
6
2019
457
0.290
Why?
Female
24
2020
27081
0.280
Why?
Drug Resistance, Neoplasm
2
2024
316
0.280
Why?
Magnetic Resonance Spectroscopy
5
2012
244
0.270
Why?
Blood Vessels
4
2015
71
0.260
Why?
Antibodies, Monoclonal
2
2007
462
0.260
Why?
Disease Models, Animal
7
2020
1436
0.250
Why?
Molecular Sequence Data
5
2012
778
0.250
Why?
Nanoparticles
2
2017
152
0.240
Why?
Cell Division
7
2010
291
0.230
Why?
Bystander Effect
1
2024
25
0.230
Why?
Human Umbilical Vein Endothelial Cells
3
2014
90
0.230
Why?
Cysteine
1
2024
50
0.230
Why?
Buthionine Sulfoximine
1
2024
13
0.230
Why?
Nanotubes
2
2021
27
0.220
Why?
Models, Molecular
4
2024
334
0.220
Why?
Thiadiazoles
2
2024
18
0.210
Why?
Flow Cytometry
2
2017
474
0.200
Why?
Cisplatin
1
2024
286
0.190
Why?
Alanine
3
2012
43
0.190
Why?
Carcinoma, Renal Cell
1
2022
101
0.190
Why?
Protein Binding
3
2012
654
0.190
Why?
Binding Sites
2
2012
362
0.190
Why?
Optical Imaging
2
2020
23
0.190
Why?
Silver
2
2021
48
0.180
Why?
Kidney Neoplasms
1
2022
174
0.180
Why?
Polyurethanes
1
2021
10
0.180
Why?
Radiation
1
2020
15
0.180
Why?
Forkhead Transcription Factors
1
2021
110
0.180
Why?
Materials Testing
1
2021
56
0.180
Why?
Spectrum Analysis
1
2020
70
0.170
Why?
Biocompatible Materials
1
2021
66
0.170
Why?
Mice, Inbred BALB C
5
2020
296
0.170
Why?
Mice, Knockout
3
2012
844
0.170
Why?
CD4-Positive T-Lymphocytes
1
2021
158
0.170
Why?
Neoplasm Transplantation
5
2007
86
0.170
Why?
Disease Progression
3
2019
829
0.170
Why?
Oxygen Consumption
1
2020
190
0.170
Why?
Lactose
2
2024
9
0.160
Why?
Immunotherapy
1
2020
235
0.150
Why?
Specimen Handling
1
2018
55
0.150
Why?
Spectrum Analysis, Raman
1
2019
55
0.150
Why?
Biological Assay
1
2018
45
0.150
Why?
Time Factors
6
2017
2935
0.150
Why?
Drug Delivery Systems
2
2019
143
0.150
Why?
Feces
1
2018
134
0.150
Why?
Indazoles
1
2018
46
0.150
Why?
Carbohydrates
1
2018
38
0.150
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
57
0.150
Why?
Temperature
1
2018
162
0.150
Why?
Cell Hypoxia
4
2015
82
0.140
Why?
Histocompatibility Antigens Class II
1
2017
37
0.140
Why?
Tumor Microenvironment
1
2019
222
0.140
Why?
Male
9
2019
25907
0.140
Why?
Drug Therapy, Combination
1
2018
384
0.140
Why?
Neoplastic Cells, Circulating
1
2017
74
0.130
Why?
Epithelial Cells
1
2018
207
0.130
Why?
Cell Line
4
2017
988
0.130
Why?
Lipopolysaccharides
2
2008
197
0.130
Why?
Umbilical Veins
4
2010
23
0.130
Why?
Enzyme Inhibitors
1
2018
377
0.130
Why?
Leukocytes
3
2006
69
0.120
Why?
Molecular Imaging
1
2015
54
0.120
Why?
Azides
1
2014
9
0.120
Why?
Fluorine Radioisotopes
1
2014
24
0.120
Why?
Tumor Burden
2
2013
130
0.120
Why?
Cell Transformation, Neoplastic
2
2007
181
0.120
Why?
Immunohistochemistry
5
2020
957
0.120
Why?
Interleukin-2
2
2021
71
0.110
Why?
Drug Synergism
2
2005
151
0.110
Why?
Cell Adhesion
3
2006
157
0.110
Why?
Piperacillin
1
2013
23
0.110
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
20
0.100
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
13
0.100
Why?
Inflammation Mediators
1
2013
111
0.100
Why?
Cell Cycle
1
2013
226
0.100
Why?
Antimicrobial Cationic Peptides
2
2008
28
0.090
Why?
Up-Regulation
2
2011
446
0.090
Why?
Neoplastic Stem Cells
1
2012
98
0.090
Why?
Metformin
1
2012
65
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Fibroblasts
1
2013
336
0.090
Why?
Glutamine
2
2024
175
0.090
Why?
Adjuvants, Immunologic
1
2011
51
0.090
Why?
Chemotherapy, Adjuvant
1
2011
121
0.090
Why?
Cell Movement
4
2006
247
0.090
Why?
Spiro Compounds
1
2010
8
0.090
Why?
Cytokines
1
2013
606
0.080
Why?
Lignans
1
2008
6
0.080
Why?
Salmonella typhimurium
1
2008
48
0.080
Why?
Amino Acid Substitution
1
2008
81
0.080
Why?
Klebsiella pneumoniae
1
2008
20
0.080
Why?
Furans
1
2008
27
0.080
Why?
Surface Properties
1
2007
72
0.070
Why?
Escherichia coli
1
2008
190
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Vascular Neoplasms
1
2007
17
0.070
Why?
Endotoxins
1
2006
31
0.070
Why?
Concept Formation
1
2006
12
0.070
Why?
Gram-Negative Bacteria
1
2006
33
0.070
Why?
Protein Structure, Secondary
2
2003
71
0.070
Why?
Interleukin-8
1
2006
85
0.070
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
18
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
226
0.060
Why?
Cloning, Molecular
1
2005
190
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
138
0.060
Why?
Angiogenic Proteins
1
2004
6
0.060
Why?
Colonic Neoplasms
1
2006
158
0.060
Why?
Histones
1
2006
297
0.060
Why?
Protein Unfolding
1
2024
6
0.060
Why?
Dietary Supplements
1
2008
449
0.060
Why?
Feasibility Studies
1
2006
390
0.060
Why?
Disulfides
1
2024
15
0.060
Why?
Diphtheria Toxin
1
2004
4
0.060
Why?
Mutagenesis, Site-Directed
1
2024
95
0.060
Why?
Protein Folding
1
2024
48
0.060
Why?
Mammary Neoplasms, Animal
1
2004
35
0.060
Why?
Osmosis
1
2003
4
0.050
Why?
Infusion Pumps
1
2003
13
0.050
Why?
Circular Dichroism
1
2003
41
0.050
Why?
Plasminogen
1
2003
2
0.050
Why?
Serum Albumin
1
2003
57
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1372
0.050
Why?
Extracellular Matrix
1
2003
109
0.050
Why?
Immune Tolerance
1
2022
84
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
833
0.050
Why?
Reactive Oxygen Species
1
2024
409
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
269
0.050
Why?
Immunity
1
2021
34
0.050
Why?
Immune System
1
2021
43
0.050
Why?
Melanoma
1
2004
280
0.050
Why?
Ethers
1
2021
8
0.050
Why?
Regenerative Medicine
1
2021
10
0.050
Why?
Tissue Scaffolds
1
2021
36
0.040
Why?
Angiogenesis Inducing Agents
1
2000
8
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
183
0.040
Why?
Tissue Engineering
1
2021
66
0.040
Why?
Bone Marrow Cells
1
2021
196
0.040
Why?
Adenocarcinoma
1
2004
397
0.040
Why?
Mice, Inbred C3H
2
2012
85
0.040
Why?
Gene Expression Profiling
1
2004
1025
0.040
Why?
Skin Neoplasms
1
2004
491
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
Inflammation
1
2022
610
0.040
Why?
NAD
1
2018
41
0.040
Why?
Microcirculation
2
2010
72
0.040
Why?
Guidelines as Topic
1
2018
109
0.040
Why?
Glutathione
1
2019
299
0.040
Why?
Microscopy, Fluorescence
1
2018
158
0.040
Why?
Phagocytosis
1
2017
44
0.040
Why?
Glycolysis
1
2017
69
0.030
Why?
Transplantation, Heterologous
2
2008
75
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Microbubbles
1
2015
25
0.030
Why?
Cell Count
1
2015
150
0.030
Why?
Stromal Cells
1
2015
75
0.030
Why?
Pressure
1
2015
104
0.030
Why?
Down-Regulation
2
2006
340
0.030
Why?
Paclitaxel
2
2006
84
0.030
Why?
Drug Evaluation, Preclinical
1
2015
145
0.030
Why?
Radiochemistry
1
2014
1
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
289
0.030
Why?
Recombinant Proteins
2
2006
476
0.030
Why?
Cell Differentiation
1
2017
640
0.030
Why?
Radiotherapy Dosage
1
2015
248
0.030
Why?
Imaging, Three-Dimensional
1
2015
150
0.030
Why?
Contrast Media
1
2015
192
0.030
Why?
Molecular Structure
1
2014
296
0.030
Why?
Ultrasonography
1
2015
435
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
326
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
9
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
78
0.020
Why?
Rats
2
2008
3292
0.020
Why?
Radiometry
1
2012
123
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
22
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
115
0.020
Why?
Receptors, Progesterone
1
2008
64
0.020
Why?
Estrogen Receptor beta
1
2008
55
0.020
Why?
Estrogen Receptor alpha
1
2008
88
0.020
Why?
Cell Growth Processes
1
2007
22
0.020
Why?
Carcinogens
1
2008
196
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
5
0.020
Why?
Neutralization Tests
1
2006
23
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
68
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
33
0.020
Why?
Acetylation
1
2006
94
0.020
Why?
Methylation
1
2006
118
0.020
Why?
Vimentin
1
2006
32
0.020
Why?
Chick Embryo
1
2006
83
0.020
Why?
Nucleic Acid Hybridization
1
2006
55
0.020
Why?
Gene Silencing
1
2006
115
0.020
Why?
Blood Proteins
1
2006
84
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Zebrafish
1
2006
55
0.020
Why?
Transfection
1
2007
356
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
56
0.020
Why?
Histone Deacetylases
1
2006
50
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
37
0.020
Why?
Pichia
1
2005
8
0.020
Why?
Gene Transfer Techniques
1
2005
41
0.020
Why?
Cyclophosphamide
1
2006
168
0.020
Why?
Neovascularization, Physiologic
1
2005
68
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
46
0.010
Why?
Membrane Proteins
1
2006
332
0.010
Why?
Indoles
1
2007
278
0.010
Why?
Skin
1
2007
388
0.010
Why?
Treatment Outcome
1
2014
5283
0.010
Why?
Necrosis
1
2004
174
0.010
Why?
Antibodies
1
2004
153
0.010
Why?
In Situ Nick-End Labeling
1
2003
52
0.010
Why?
Base Sequence
1
2004
639
0.010
Why?
Sequence Homology, Amino Acid
1
2003
144
0.010
Why?
Epigenesis, Genetic
1
2006
372
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
572
0.010
Why?
Mice, Transgenic
1
2004
540
0.010
Why?
RNA, Messenger
1
2004
1089
0.010
Why?
Endothelial Growth Factors
1
2000
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
13
0.010
Why?
Fibroblast Growth Factor 2
1
2000
34
0.010
Why?
Lymphokines
1
2000
19
0.010
Why?
Scrotum
1
2000
30
0.010
Why?
Interleukin-1
1
2000
105
0.010
Why?
Models, Biological
1
2002
716
0.010
Why?
Breast Neoplasms
1
2004
1201
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description